NEW research is exploring cost-effective, non-invasive ways to diagnose Barrett's esophagus, a condition that raises the risk of oesophageal cancer.
Affecting 2-4% of Australians, mostly men over 40, Barrett's esophagus often goes undetected, as its symptoms are similar to heartburn.
Published in the Journal of Gastroenterology and Hepatology, the study, led by Dr Norma Bulamu from the College of Medicine and Public Health, proposes a multi-step screening approach: initial risk assessment and less-invasive tests, followed by an endoscopy only if needed.
The method could reduce costs and patient discomfort associated with endoscopies, the current test for diagnosis.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Oct 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Oct 24
